If you're looking for an investment that's innovative and involving the bio-tech sector, take a look at Immunotech Laboratories (IMMB). The company's work in killing cancer is based on an approach called "Immunotherapy" The stock ticker is IMMB and Immunotech Laboratories has been called an "undervalued asset" by analysts. More info at Zennie62.com: Immunotech Laboratories (IMMB): Revolutionary Cancer Treatment, New R&D Facilities #BeatCancer
